Today, I registered the domains Joosse.eu and Joosse.net. This website can now be reached though the addresses http://joosse.eu, http://joosse.net, and http://joosse.info, or directly using http://simon.joosse.eu, http://simon.joosse.net, and http://simon.joosse.info.

A nice article showing that "BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A". Written by Puppe et al. where I also have contributed to.

Published in Breast Cancer Research. Now also added to the section Publications

And to close April with a third co-authored publication: Deletion of Exons 1a-2 of BRCA1: A Rather Frequent Pathogenic Abnormality. By Ans van den Ouweland, pulished in Genetic Testing and Molecular Biomarkers.

This is the second study which uses the BRCA1-classifier which I plublished in 2008.

The next day another co-authored publication: Array comparative genomic hybridization identifies a distinct DNA copy number profile in renal cell cancer associated with hereditary leiomyomatosis and renal cell cancer. By Taru Koski, published in Genes, Chromosomes and Cancer.

The first co-authored publication of 2009: High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer. By Henne Holstege, published in Cancer Research.

My first work day at the Univeristy Medical Center Hamburg-Eppendorf (UKE). Here I will finish my PhD in the comming few years. My main question is to characterize tumor cells that are circulating in tthe patients blood. These are the cells that will form the metastases.

Everything packed and ready to go. I leave the Netherlands and move to Germany. It is 475 km from Amsterdam (the Netherlands) to Hamburg (Germany).

I have to start practicing my German again, it has been over 12 years since I learned German in secondary education.